Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05019976 · ClinicalTrials.gov registry record · NA
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
A NA study of Lymphoma and Non-Hodgkin Lymphoma, sponsored by University of Chicago.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05019976 is a NA study of Lymphoma and Non-Hodgkin Lymphoma that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 30 participants, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05019976, a NA study of Lymphoma and Non-Hodgkin Lymphoma, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study focuses on using shortened courses of radiation for participants with relapsed/refractory Hodgkin/Non-Hodgkin lymphoma. Treatment radiation over 5-6 weeks is often standard of care for many people with lymphoma, but doctors leading this study aim to find out if using radiation for a shorter period of time can be safe for treating lymphoma and if so, what is the safest shortened dose of radiation for participants.
Conditions Studied
Interventions
- RADIATION Radiation - Dose Level 0
- RADIATION Radiation - Dose Level 1
- RADIATION Radiation - Dose Level 2
- RADIATION Radiation - Dose Level 3
- RADIATION Radiation - Dose Level 4
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-09-30 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05019976
The ClinicalTrials.gov registry entry for NCT05019976 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (94% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Lymphoma appearing as the primary indexed condition, and to 5 interventions - of which Radiation - Dose Level 0 is the first listed.
NCT05019976 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05019976 about?
NCT05019976 is a clinical study titled "Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma". This study focuses on using shortened courses of radiation for participants with relapsed/refractory Hodgkin/Non-Hodgkin lymphoma. Treatment radiation over 5-6 weeks is often standard of care for many people with lymphoma, but doctors leading this study aim to find out if using radiation for a short...
What is the current status of trial NCT05019976?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-09-30. Estimated completion is 2027-12-01.
What conditions does trial NCT05019976 study?
This clinical trial studies the following conditions: Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma.
What interventions are being tested in trial NCT05019976?
The interventions under investigation include: Radiation - Dose Level 0 (RADIATION), Radiation - Dose Level 1 (RADIATION), Radiation - Dose Level 2 (RADIATION), Radiation - Dose Level 3 (RADIATION), Radiation - Dose Level 4 (RADIATION).
Who is sponsoring clinical trial NCT05019976?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05019976 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.